Woolworths-backed telehealth start-up Eucalyptus has made around $200 million in the past 18 months selling weight-loss services and drugs such as Wegovy, and plans to revive its mothballed men’s longevity service in Britain.
Eucalyptus has become the largest online weight-loss medication company in the country since it was founded in 2019. Investors including Blackbird Ventures, Woolworths’ venture capital arm and Mary Meeker’s Bond Capital have poured in about $150 million to value it at $560 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.